AI CAPITAL INTELLIGENCE
金沙江联合资本润璞医疗基金 | Institution profile
Institution at a glance
Runpu Healthcare Fund is a healthcare-focused fund managed by GSR United Capital. Managing Partner Wang Xiaoyan says she has led its formation since 2021. Disclosed areas include therapeutics, in-vitro diagnostics and life-science platforms, with focus on neurology, women’s health, immunology and oncology.
Source verification date: · GSR United Capital’s broader strategy, offices and portfolio are not fund-specific. Wang Xiaoyan’s reported experience leading 30-plus life-science investments is her personal track record, not the complete Runpu portfolio. Tianwu Technology’s Series A++ total was several hundred million yuan; Runpu’s amount was not disclosed.
Names follow their disclosed form. Descriptive English renderings of Chinese names are not verified legal names. Original quotations are shown in their source language.
Key facts
Organization background
The published team includes Managing Partner Wang Xiaoyan and Vice President Sha Zijie. Their biographies describe healthcare investment, project diligence and life-science experience; personal career records are not fund-only portfolio attribution.
Management and roles
- GSR United Capital · Managing Partner, Runpu Healthcare Fund
Current role (as reported in the cited source)
- GSR United Capital · Vice President, Runpu Healthcare Fund
Current role (as reported in the cited source)
- Harbin Pharmaceutical Group · Senior Director, Business Development
Before GSR United Capital · Role listed in Wang Xiaoyan’s public biography.
- Jinpu Healthcare Fund · Partner
Before GSR United Capital · Role listed in Wang Xiaoyan’s public biography.
- Frost & Sullivan · Biopharma consulting manager
Before Runpu · Sha Zijie’s biography says he participated in dozens of IPO projects.
Public record
- A 2026 report names Runpu Healthcare Fund as an existing shareholder that continued investing in Tianwu Technology’s Series A++ round. The company raised several hundred million yuan; the fund’s individual amount was not disclosed.
Official contact details
- Manager website (not fund-specific): GSR United Capital
- Manager business-plan email (not fund-specific): bp@gsrunited.com
- Manager public phone: 010-85317088
- Manager’s Beijing office: 北京市朝阳区东方东路19号院5号楼亮马桥外交办公楼D1栋1602
- Manager’s Hangzhou office: 浙江省杭州市萧山经济技术开发区博奥路1728号机器人中心A座6层
- Manager’s Shenzhen office: 深圳市南山区深南大道9018号华侨城大厦701
Sources
- 1. GSR United Capital · Official website
金沙江联合资本（GSR United Capital）专注于高科技产业股权投资，重点关注先进制造、新一代信息技术、产业互联网与数字化企业服务、生物医药等领域。自2009年创立以来，基金合伙人和团队成员积累了企业运营、投资及风险管理经验。BP投放邮箱bp@gsrunited.com，电话010-85317088。Original Chinese-language excerpt
- 2. Wang Xiaoyan · GSR United Capital
2021年起任金沙江联合润璞医疗基金管理合伙人，全面负责筹备募集设立医疗基金。主要投资方向为医疗健康行业，专注神经、妇科等细分治疗领域，免疫与肿瘤等重大疾病，重点投资药、体外诊断及新型生命科学技术平台等。主导投资了信达生物、长风药业、贝康医疗、天演药业、华大智造、来凯医药等30余个海内外生命科学项目。Original Chinese-language excerpt
- 3. Sha Zijie · GSR United Capital
2021年起担任金沙江联合润璞医疗基金副总裁，主要负责项目开发、尽职调查、项目谈判、投后管理、GP管理与其他内部活动等。曾任职于弗若斯特沙利文咨询担任生物医药部门咨询经理，任职期间深度参与数十个IPO项目。Original Chinese-language excerpt
- 4. Tianwu Technology raises several hundred million yuan in Series A++ financing
老股东 启明创投、涌铧投资、金沙江联合资本润璞医疗基金、本草资本、上海科创基金持续加注Original Chinese-language excerpt